Cost of Treatment of Chronic Spontaneous Urticaria in Turkey

HTML  XML Download Download as PDF (Size: 406KB)  PP. 1098-1103  
DOI: 10.4236/health.2016.811114    2,168 Downloads   3,363 Views  Citations

ABSTRACT

Chronic Spontaneous Urticaria (CSU) is a chronic disease with significant negative impact on quality of life of patients. The direct and indirect costs of the disease can be substantial both for the health care system and society. The aim of this research is to estimate the cost of mild, moderate and severe CSU in Turkey and to forecast the cost of the disease from the payer (Social Security Institution—SSI) perspective. Expert opinions with Delphi technique were used in order to determine the cost items and their frequency. A questionnaire was designed to outline resources used in the out-patient, inpatient and emergency care episodes and was answered by dermatologists followed by a consensus meeting. Unit costs were calculated from the price list of the SSI. The annual total cost of treating the disease to the SSI was estimated as 262,111,978TL (94,417,870€) comprising 0.06% of the total healthcare budget in 2013. Since there is limited information about the cost of CSU in Turkey, the methodology and results of this study are unique and very important.

Share and Cite:

Tatar, M. , Şentürk, A. , Oğuzhan, G. , Tuna, E. , Mat, C. , Başkan, E. , Artüz, F. , Gürer, M. , Atakan, N. , İnalöz, S. , Çavuşoğlu, S. , Keskinaslan, A. and Şaylan, İ. (2016) Cost of Treatment of Chronic Spontaneous Urticaria in Turkey. Health, 8, 1098-1103. doi: 10.4236/health.2016.811114.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.